Scientific American reporter Lindsay Brownell writes that MIT researchers have developed a technique to enlarge pathology samples. “Not only are expanded samples easier to see because they are larger and more transparent, fluorescent tags and other labels can also be added to track individual molecules of interest.”
Boston Herald reporter Lindsay Kalter writes that MIT researchers have developed a hydrogel-based capsule that can slowly release medications over several days and could help patients follow complex treatment regimens. “A lot of people do not take their medication as prescribed,” explains postdoc Jinyao Liu. “With this, you just need a single dose.”
Anne Pycha of Scientific American writes about three new methods that could be used to help detect Parkinson’s disease and enable early intervention. A new typing test developed by MIT researchers could be used to identify individuals with possible signs of Parkinson’s, “by analyzing key hold times (the time required to press and release a key).”
FOX 25’s Bob Dumas reports on a study by MIT Medical that shows most parents could successfully perform strep tests at home. David Diamond, associate medical director of MIT Medical, explains that in the healthcare field, “we are empowering patients to help us take care of their health,” adding that this test, “would be yet another advance in this regard.”
Henri Termeer, a life member of the MIT Corporation who was known as one of the founding fathers of the biotech industry, died at age 71, write Robert Weisman and Bryan Marquard for The Boston Globe. Termeer was, “a key leader in the biotech revolution that placed Massachusetts at the nexus of cutting-edge research and development.”
Reporting for the PBS NewsHour, Nsikan Akpan highlights a new study co-authored by MIT researchers that examines how many NIH grants lead to new patents and medications. Prof. Pierre Azoulay explains that the study, “provides evidence that the research done in the public sector is useful — it’s relevant for the research done by private-sector firms.”
Newsweek reporter Jessica Wapner writes about a new study by MIT researchers that provides evidence that NIH funding contributes to a large number of patents in the field of biomedicine. The findings indicate that NIH-funded research “is not being done in an ivory tower,” explains Prof. Pierre Azoulay. “Companies use it as input in their own discovery efforts.”
Nature reporter Elie Dolgin writes about Prof. Pierre Azoulay’s new research that shows NIH funding has a significant impact on innovation in the field of biomedicine. Azoulay explains that from an economic standpoint the U.S. is “under-investing overall” in biomedical research.
Los Angeles Times reporter Melissa Healy writes that a new study by Prof. Pierre Azoulay examining the impact of NIH-funded research shows that NIH funding, “fuels the kinds of innovations that drive the U.S. economy.” Azoulay explains, “NIH public funding expenditures have large effects on the patenting output of the private sector.”
A study by Prof. Pierre Azoulay demonstrates the significant impact of NIH funding on biomedical patents, reports Carolyn Johnson for The Washington Post. Azoulay explains, “if your view was that the research done by academics...[has] no ramifications for the real world and the development of new medicines — well, that view is not correct.”
New Scientist reporter Sam Wong writes that MIT researchers used high-speed cameras to examine how raindrops can spread soil bacteria. “The researchers estimate that a single raindrop can transfer 0.01 per cent of bacteria on the soil surface into the air, and up to a quarter of bacteria emitted from the land might become airborne in this way.”
Using high-speed cameras and fluorescent dye, MIT researchers have uncovered how rain drops can spread soil bacteria, reports Rae Ellen Bichell for NPR. The researchers found that in a few microseconds “a single raindrop can create hundreds of tiny airborne droplets, each one carrying as many as several thousand live bacteria.”
Popular Science reporter Kendra Pierre-Louis writes about a new study by MIT researchers that examines how rain drops help spread soil bacteria. The researchers found that “a single rain drop can transfer 0.01 percent of bacteria on the soil surface to the atmosphere.”
MIT researchers have developed a new drug capsule that can deliver doses of medication over the course of several weeks, reports Robby Berman for Slate. Berman explains that the star-shaped device is like “a little pharmacy stationed in the stomach, ready to dispense doses at the desired times.”
Prof. Robert Langer speaks with Kathryn Nave of Wired about the future of drug delivery. Langer explains that a problem facing medical professionals is that many drugs are not taken regularly or as prescribed, and describes how he is developing a “long-acting pill that you could swallow to release the right drug dosage for weeks.”